Fresenius Medical Care AG & Co. (FMS)

NYSE: FMS · Delayed Price · USD
30.20
0.09 (0.30%)
At close: May 25, 2022 4:00 PM
30.35
0.15 (0.50%)
Pre-market:May 26, 2022 5:51 AM EDT
Market Cap17.70B
Revenue (ttm)17.96B
Net Income (ttm)877.72M
Shares Out586.06M
EPS (ttm)1.58
PE Ratio19.09
Forward PE14.03
Dividend$0.49 (1.63%)
Ex-Dividend DateMay 13, 2022
Volume686,998
Open29.89
Previous Close30.11
Day's Range29.87 - 30.37
52-Week Range28.75 - 42.45
Beta0.94
AnalystsHold
Price Target34.13 (+13.0%)
Earnings DateMay 5, 2022

About FMS

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage rena...

IndustryHealth Care Providers & Services
IPO DateSep 19, 1996
CEORice Powell
Employees122,635
Stock ExchangeNYSE
Ticker SymbolFMS
Full Company Profile

Financial Performance

In 2021, FMS's revenue was $17.62 billion, a decrease of -1.35% compared to the previous year's $17.86 billion. Earnings were $969.31 million, a decrease of -16.75%.

Financial Statements

Analyst Forecast

According to 28 analysts, the average rating for FMS stock is "Hold." The 12-month stock price forecast is 34.13, which is an increase of 13.01% from the latest price.

Price Target
$34.13
(13.01% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Fresenius Medical Care Celebrates Diversity and Unity of a Global Nurse Workforce

HONG KONG--(BUSINESS WIRE)-- #healthcare--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced its global ‘United in Care' c...

2 weeks ago - Business Wire

Fresenius Medical (FMS) Q1 Earnings & Revenues Top Estimates

Fresenius Medical's (FMS) first-quarter earnings benefit from strong performance across all the geographic regions and segments.

2 weeks ago - Zacks Investment Research

Fresenius Medical (FMS) Launches Campaign to Boost Kidney Care

Fresenius Medical's (FMS) My Reason campaign will help scientists understand genetic variations in patients with chronic kidney disease in a better way.

1 month ago - Zacks Investment Research

Fresenius Medical Care Launches My Reason® Campaign to Enroll Patients in Groundbreaking Renal-focused Genomic Registry

Goal of 100,000 Participants Within Five Years to Help Scientists Better Understand Genetic Variations in Patients with Chronic Kidney Disease WALTHAM, Mass. , April 13, 2022 /PRNewswire/ -- Fresenius M...

1 month ago - PRNewsWire

Fresenius Medical Care Appoints Dr. Amaka Eneanya as Head of Strategy and Operations for Company's Global Medical Office

WALTHAM, Mass. , April 5, 2022 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, announced today the appointment of noted...

1 month ago - PRNewsWire

Fresenius Medical's (FMS) Merger Deal to Improve Kidney Care

Fresenius Medical's (FMS) merger deal to build an independent entity to transform kidney care and health equity throughout the United States.

2 months ago - Zacks Investment Research

How Fresenius Medical Care's Superhero Is Helping Bridge the Knowledge Gap to Better Kidney Health

HONG KONG--(BUSINESS WIRE)-- #chronickidneydisease--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has today announced the social medi...

2 months ago - Business Wire

Fresenius Medical (FMS) Q4 Earnings Beat Estimates, Up Y/Y

Fresenius Medical's (FMS) fourth-quarter earnings benefit from strong performance across all the geographic regions and segments.

3 months ago - Zacks Investment Research

Fresenius's Q4 Operating Income Hit By COVID-19 Related Headwinds, Targets Earnings Growth In FY22

Fresenius Medical Care AG & Co's (NYSE: FMS) Q4 net income increased 29% Y/Y to €229 million, while quarterly net income was up 23% at constant currency.  Adjusted net income for Q4 declined by 29% to €...

3 months ago - Benzinga

Fresenius Medical Care Asia Pacific Receives Prestigious ACHS Global Quality Improvement Award

HONG KONG--(BUSINESS WIRE)-- #chronickidneydisease--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, was presented with the prestigious ...

5 months ago - Business Wire

Fresenius Medical Care launches new mobile app to empower and engage nurses

HONG KONG--(BUSINESS WIRE)-- #clinic--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced the launch of Carrie, a custom-bu...

5 months ago - Business Wire

Fresenius Medical's (FMS) New Dialyzer to Boost Patient Outcome

Fresenius Medical's (FMS) latest dialyzer is expected to better serve dialysis patients because of its design.

5 months ago - Zacks Investment Research

Fresenius Medical Care Unveils Intelligent Home Dialysis Solutions at China International Import Expo (CIIE)

HONG KONG--(BUSINESS WIRE)-- #china--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today presented its advances in home dialysis solu...

6 months ago - Business Wire

Fresenius Medical (FMS) Q3 Earnings Beat Estimates, Down Y/Y

Fresenius Medical's (FMS) third-quarter earnings benefit from strong performance across the regions, Asia Pacific and Latin America.

6 months ago - Zacks Investment Research

Generation Income Properties Announces Agreement for Pending $3.1 Million Transaction

TAMPA, FL / ACCESSWIRE / November 1, 2021 / Generation Income Properties, Inc. (NASDAQ:GIPR) ("GIP" or the "Company") announced the signing of a definitive Purchase and Sale Agreement under which the Co...

Other symbols:GIPR
6 months ago - Accesswire

New Strong Sell Stocks for October 14th

ARNC, BSET, FMS, OCUL, and PTGX have been added to the Zacks Rank #5 (Strong Sell) List on October 14, 2021.

Other symbols:ARNCBSETOCULPTGX
7 months ago - Zacks Investment Research

Ominous Death Cross Forms On Fresenius Medical Care's Chart

If history is any guide, there may be trouble ahead for shares of Fresenius Medical Care(NYSE:FMS). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the...

8 months ago - Benzinga

Fresenius Medical's (FMS) Deal to Boost Home Dialysis in Japan

Fresenius Medical (FMS) partners with JMS Co. Ltd. to provide innovative home dialysis therapies to the aging population in Japan to improve their wellbeing.

8 months ago - Zacks Investment Research

Fresenius Medical Care Partners with JMS Co. Ltd. to Advance Home Dialysis Treatment in Japan

HONG KONG--(BUSINESS WIRE)-- #Japan--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has today announced a strategic distribution partn...

8 months ago - Business Wire

Fresenius Medical (FMS) Q2 Earnings Beat Estimates, Up Y/Y

Fresenius Medical's (FMS) second-quarter earnings benefit from strong performance across the regions, EMEA, Asia Pacific and Latin America.

9 months ago - Zacks Investment Research

Recap: Fresenius Medical Care Q2 Earnings

Shares of Fresenius Medical Care (NYSE:FMS) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were down 31.82% over the past year to $0.45, which missed the esti...

9 months ago - Benzinga

15 European Dividend Aristocrats to Diversify Your Portfolio

Plenty of investors focus in on dividends, and dividend aristocrats, but if those investors only look in the U.S. they could be missing out. The post 15 European Dividend Aristocrats to Diversify Your P...

10 months ago - InvestorPlace

Fresenius Medical's (FMS) Xenios Gets NMPA Nod for ECMO System

Fresenius Medical (FMS) company receives expedited approval from NMPA permitting the Xenios AG's console and patient kits for ECMO therapy in China.

10 months ago - Zacks Investment Research

Fresenius Medical's (FMS) Training Center to Boost Patient Care

Fresenius Medical (FMS) inaugurates new training center in Korea to help in the improvement of patient care by offering comprehensive education programs for healthcare professionals.

10 months ago - Zacks Investment Research

Fresenius Medical Care Supports Education for Healthcare Professionals in Korea With the Opening of Its First Trainin...

HONG KONG--(BUSINESS WIRE)-- #chronickidneydisease--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, recently announced the grand openin...

10 months ago - Business Wire